Latest News
CKD Corporation
- Lorundrostat Reduces High BP, Albuminuria in CKD Patients: Launch-HTN Substudy
- SGLT2i Benefit Mortality, Cognition in Older CKD Patients
- Semaglutide in Type 2 Diabetes and CKD: Katherine R. Tuttle, MD, FASN
- CKD Risk Stratification, Payment Models, LLMs Aim to Close Care Gaps
- Lorundrostat Lowers BP, Albuminuria in CKD With Uncontrolled Hypertension
- Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD
- Intensive BP Lowering Cuts CV Events Regardless of CKD Status
- Kidney Week 2026: Previewing Advances in CKD
- Intensive BP Control Cuts CV Risk Regardless of CKD Status
- Living with CKD and Coronary Artery Disease
- Dapagliflozin - Five Years since CKD Approval: Revisiting 5 Milestones in CKD Care
- Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
Headlines from the last 30 days, linking to the original publishers. See all market news →